TY  - GEN
AU  - Valgimigli,Marco
AU  - Bolognese,Leonardo
AU  - Anselmi,Maurizio
AU  - Campo,Gianluca
AU  - Rodriguez,Alfredo E
AU  - de Cesare,Nicoletta
AU  - Cohen,David J
AU  - Sheiban,Imad
AU  - Colangelo,Salvatore
AU  - Pasquetto,Giampaolo
AU  - Hamon,Martial
AU  - Vranckx,Pascal
AU  - Ferrario,Maurizio
AU  - Prati,Francesco
AU  - Agostoni,Pierfrancesco
AU  - Malagutti,Patrizia
AU  - Arcozzi,Chiara
AU  - Parrinello,Giovanni
AU  - Vassanelli,Corrado
AU  - Ferrari,Roberto
AU  - Percoco,Gianfranco
TI  - Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial
SN  - 1097-6744
PY  - 2007///0702
KW  - Abciximab
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Clinical Trials, Phase III as Topic
KW  - Drug Administration Schedule
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Infusions, Intravenous
KW  - Metals
KW  - Myocardial Infarction
KW  - therapy
KW  - Platelet Glycoprotein GPIIb-IIIa Complex
KW  - antagonists & inhibitors
KW  - Randomized Controlled Trials as Topic
KW  - Research Design
KW  - Sirolimus
KW  - Stents
KW  - Tirofiban
KW  - Tyrosine
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ahj.2007.03.023
ER  -